The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/Ib study of enzalutamide and gemcitabine and cisplatin in bladder cancer.
 
Shilpa Gupta
Honoraria - Genentech; pfizer; Seagen
Consulting or Advisory Role - Genentech; pfizer; Seagen
Speakers' Bureau - Genentech
Research Funding - Astellas Medivation (Inst); Innocrin Pharma (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Mayer N. Fishman
Consulting or Advisory Role - Alkermes (I); Eisai (Inst)
Speakers' Bureau - GlaxoSmithKline; Pfizer
Research Funding - BMS Brazil (Inst); Exelis (Inst)
 
Jasreman Dhillon
No Relationships to Disclose
 
Anthony Martin Magliocco
No Relationships to Disclose
 
John Puskas
No Relationships to Disclose
 
Gisela Caceres
No Relationships to Disclose
 
Taymeyah E Al-Toubah
No Relationships to Disclose
 
Badrinath R. Konety
Stock and Other Ownership Interests - Axogen Inc
Consulting or Advisory Role - Takeda
Research Funding - Genomic Health (Inst); Heat Biologics (Inst); Myriad Genetics (Inst); Photocure (Inst)
 
Matthew Lindemam
No Relationships to Disclose
 
Gautam Gopalji Jha
No Relationships to Disclose
 
Jingsong Zhang
No Relationships to Disclose